Bellevue Group AG

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1674546 Zurich, V8

Position in TEVA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$11,719,058

+$4,186,589 QoQ

Shares Held

345,899

+38.3% QoQ

Ownership

0.030%

of shares outstanding

% of Portfolio

0.25%

of 13F equity value

Holder Rank

#140

of 671 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Bellevue Group AG holds $124,492,646 across 6 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (9.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	188,515	$102,143,081
2	TEVA	Teva Pharmaceutical Industries Ltd This page	345,899	$11,719,058
3	ALKS	Alkermes plc.	120,243	$6,300,733
4	NBIX	Neurocrine Biosciences Inc	24,037	$4,051,195
5	VTRS	Viatris Inc	15,778	$250,554
6	ZTS	Zoetis Inc.	390	$28,025

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,719,058	345,899	+38.3%	Shares	Defined	2026-08-14
2026-03-31	$7,532,469	250,082	-23.7%	Shares	Defined	2026-05-15
2025-12-31	$10,232,604	327,863	-22.7%	Shares	Defined	2026-02-17
2025-09-30	$8,565,931	424,056	+0.6%	Shares	Defined	2025-11-14
2025-06-30	$7,064,356	421,501	+1357.0%	Shares	Defined	2025-08-14
2025-03-31	$444,654	28,930	-52.3%	Shares	Defined	2025-05-14
2024-12-31	$1,335,579	60,598	-14.4%	Shares	Defined	2025-02-14
2024-09-30	$1,276,194	70,821	-54.2%	Shares	Defined	2024-11-14
2024-06-30	$2,515,012	154,770	+8.8%	Shares	Defined	2024-08-14
2024-03-31	$2,006,625	142,213	-53.1%	Shares	Defined	2024-05-15
2020-03-31	$2,720,940	303,000	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.